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The mutational pattern of CFTR mutations is largely unknown in Oman and
most other Arab countries. We describe initial investigations for establishing an
Omani mutational panel by analyzing 22 alleles of non-related CF patients in a
randomly selected subset of our patient cohort in North Al Bathina, Sultanate
of Oman. The major disease-causing mutation is S549R. S549R was detected
in 77.3% of the investigated alleles. In ﬁve alleles, the mutations could not be
identiﬁed. One patient is a compound heterozygote with the mutation S549R and
another yet-unidentiﬁed mutation. The most common Caucasian CFTR mutation,
delF508, was absent in the investigated cohort. S549R eliminates the restriction
site of DraIII in exon 11. Thus, this speciﬁc property can be utilized for fast and
efﬁcient prescreening and mutation detection upon clinical suspicion of CF. The
phenotype of our S549R homozygotes is severe and characterized by failure to
thrive with frequent pulmonary exacerbations. Analysis of fecal elastase in S549R
homozygotes revealed severe exocrine pancreatic insufﬁciency. The average sweat
conductivity and chloride concentration were 116±3.6mmol/l and 102±5.7mmol/l,
respectively. The currently poor outcome of our CF patients with a life expectancy
of 10.5±1.8 years cannot be attributed to S549R alone. Due to socio-cultural and
medical-educational factors, 90% of the patients are below the 50 BMI percentile
of the WHO child growth chart.
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Introduction: Cystic Fibrosis (CF) is deﬁned as the most frequent monogenic
autosomal recessive disease in the Caucasian population, being the major cause
of death in children and young adults. In the European population, the frequency
of CF carriers is 1 in 2500 births, with variations according to ethnic group and
geographical location. However, in Portugal, the prevalence of CF is unknown. The
aim of the present study is to evaluate the prevalence of CF by studying a group of
individuals (912 samples) randomly selected and representative of the Portuguese
population.
Methods: Initial screening was performed in 100 samples by complete DNA
sequencing of exons 4, 7, 9, 10, 11, 12, 13, 14a, 15 and 17b of the CFTR gene.
Results: Mutation G576A was identiﬁed in 3 samples (3%), mutation R668C was
identiﬁed in 2 samples (2%) and three other mutations, D443Y, F508del and L976S,
were identiﬁed in 1 sample (1%). Regarding CFTR polymorphisms, c.1408A>G
was detected in 85 samples (85%), c.2562T>G in 54 samples (54%), IVS8-5T and
c.1584G>A in 8 samples (8%), c.3140-92T>C in 7 samples (7%), c.1523T>G
in 3 samples (3%) and c.1052C>G, c.1614T>C, c.2898G>A, c.3154T>G and
c.3285>T were detected in 1 sample (1%). c.1614T>C, in exon 11, was identiﬁed
for the ﬁrst time in this study.
Conclusions: In this preliminary analysis, 8 CFTR mutations were detected in 100
samples, corresponding to a 4% of carrier frequency in 200 studied alleles, and
a novel polymorphism (c.1614T>C) was identiﬁed. The results obtained with the
present study are expected to contribute to a better knowledge of the Portuguese
CFTR gene mutations spectrum as well as to improve the CF diagnosis used in
Portugal.
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Patients with CF display a broad spectrum of clinical variation, inﬂuenced by
mutation. F508del is the most common mutation in cystic ﬁbrosis (CF). The aim
of this study was to determine the prevalence of F508del and its relation to clinical
manifestation in CF.
Method: This is a single CF unit retrospective study, analyzing the genetic and
clinical characteristics of 90 genotyped children from Albania. All children were
analyzed for 31 mutations. In all patients were recorded age at diagnosis, presenting
symptoms, sweat-chloride concentration, and complication.
Results:We have analyzed 75% of all the patients in registry from 1992 till October
2011. The mutations found were: F508del, G542X, 621+1G>T, G85E, R1158X,
E822X, N1303K. 74.4% of analyzed children were homozygous for F508del,
14.5% were heterozygous for F508del (6 cases with one unknown mutation, and
7 cases in combination with other mutations). 52% of children homozygous for
F508del presented with edema, anemia and hypoproteinemia, as opposed to only
15% of children with other mutations, or combination of F508del/other mutations.
Meconium ileus was present in 4.4% of patients homozygous for F508 mutations,
as opposed to 14% of patients heterozygous for F508 mutations and no patients
with only other mutations. Concerning the complications there was no signiﬁcant
difference for liver disease based only on ultrasound abnormality. In our patients
only one have had cirrhosis and diabetes.
Conclusion: The presence of F508del homozygous is high in Albanian population,
but cannot predict prognosis in CF patients at time of their diagnosis.
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Objectives: Demographic and clinical data from cystic ﬁbrosis (CF) patients
followed at the centralized pediatric CF center were published in the European
Cystic Fibrosis Patient Registry Report 2007, but there is paucity of available data
on the state’s adult CF population. Study aim: to describe characteristics of all
known patients in Slovenia in 2010 and compare them to earlier data of 2007.
Methods: Data from all patients followed at state’s centralized pediatric CF center
and two adult CF centers were collected, reviewed and compared to previously
published report.
Results: A total of 88 patients were identiﬁed (female 58%), mean age 16.0 yrs,
36.4% were older than 18 yrs. 2007 report had information on 50 patients; only 4.0%
were over 18 yrs. Median age at diagnosis was 4 months and 2 were diagnosed in
adulthood. Forty-eight percent of patients were homozygous for DF508 mutation.
The comparison in pulmonary function shows improvement especially in the group
of adolescent patients (15−19 yrs) with a median FEV1 (% pred) of 92.0 (IQR
82.0–103.0). The nutritional status of patients in 2010 was better than in 2007 with
most of the children and adolescents having BMI between 25th and 50th percentiles
and adults having a mean BMI of 22.2 (SD ±2.5). In 2010 10% of patients had
chronic Pseudomonas aeruginosa (PA) colonization, which is half as much as in
2007. In 2010 eight cases (9.1%) of lung transplantation were reported, performed
at a mean age of 28.6 yrs.
Conclusions: The most recent data describing Slovenian CF population suggest
improvement in nutritional status and pulmonary function, lower prevalence of
chronic PA infection and include CF patients after lung transplantation.
